The Relevance of the Endothelium in Cardiopulmonary Disorders
- PMID: 39273209
- PMCID: PMC11395528
- DOI: 10.3390/ijms25179260
The Relevance of the Endothelium in Cardiopulmonary Disorders
Abstract
The endothelium is a cell monolayer that lines vessels and separates tissues from blood flow. Endothelial cells (ECs) have a multitude of functions, including regulating blood flow and systemic perfusion through changes in vessel diameter. When an injury occurs, the endothelium is affected by altering its functions and structure, which leads to endothelial dysfunction, a characteristic of many vascular diseases. Understanding the role that the endothelium plays in pulmonary vascular and cardiopulmonary diseases, and exploring new therapeutic strategies is of utmost importance to advance clinically. Currently, there are several treatments able to improve patients' quality of life, however, none are effective nor curative. This review examines the critical role of the endothelium in the pulmonary vasculature, investigating the alterations that occur in ECs and their consequences for blood vessels and potential molecular targets to regulate its alterations. Additionally, we delve into promising non-pharmacological therapeutic strategies, such as exercise and diet. The significance of the endothelium in cardiopulmonary disorders is increasingly being recognized, making ECs a relevant target for novel therapies aimed at preserving their functional and structural integrity.
Keywords: COVID-19; acute respiratory distress syndrome; cardiopulmonary disorders; chronic obstructive pulmonary distress; endothelium; pulmonary hypertension; therapeutic strategies.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Endothelial microparticles: missing link in endothelial dysfunction?Eur J Prev Cardiol. 2013 Jun;20(3):496-512. doi: 10.1177/2047487312445001. Epub 2012 Apr 10. Eur J Prev Cardiol. 2013. PMID: 22496273 Review.
-
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.Pharmacol Rev. 2021 Jul;73(3):924-967. doi: 10.1124/pharmrev.120.000096. Pharmacol Rev. 2021. PMID: 34088867 Review.
-
Endothelium-targeted gene and cell-based therapies for cardiovascular disease.Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1761-74. doi: 10.1161/01.ATV.0000142363.15113.88. Epub 2004 Aug 12. Arterioscler Thromb Vasc Biol. 2004. PMID: 15308553 Review.
-
Endothelial dysfunction and cardiometabolic diseases: Role of long non-coding RNAs.Life Sci. 2016 Dec 15;167:6-11. doi: 10.1016/j.lfs.2016.11.005. Epub 2016 Nov 9. Life Sci. 2016. PMID: 27838210 Review.
-
[ENDOTHELIAL DYSFUNCTION AND OBSTRUCTIVE LUNG PATHOLOGY].Ross Fiziol Zh Im I M Sechenova. 2016 Dec;102(12):1420-32. Ross Fiziol Zh Im I M Sechenova. 2016. PMID: 30198245 Review. Russian.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources